Updated Date: Tue, 31 Jan 2023 00:00:00 EST

Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure

Financing will allow company’s development of DNA synthesis chip technology to commercial scale

Researchers have used single carbon atom doping to form four chemical bonds in one step. Gamma-lactams (cyclic molecules […]

Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar

Charity highlights the need to find kidney cancer early and for better guidance among doctors

PharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as […]

MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn’s Disease

Partnership involves the study of real-time patient data and identification of adherence issues

Updated Date: Thu, 26 Jan 2023 00:00:00 EST